Cardiology
Studies from India, the People's Republic of China and Japan provide new cardiology data
Published in Hospital Business Week, February 25th, 2007
Study 1: Fresh data on cardiology are presented in the report "Lupeol and its ester inhibit alteration of myocardial permeability in cyclophosphamide administered rats." According to a study from Chennai, India, "Cyclophosphamide (CP), an alkylating agent widely used in cancer chemotherapy causes cardiac membrane damage. Lupeol, a pentacyclic triterpene, isolated from Crataeva nurvala stem bark and its ester, lupeol linoleate possess a wide range of medicinal properties."
"The effect of lupeol and its ester was evaluated in CP...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Allergy & Immunology
Pollinex Quattro grass dosing begins in first-ever global allergy vaccine trial - Ascites
Researchers at Hamad Medical Corporation, Department of Medicine have published new data on ascites - Birth Defects
Birth defect hospitalizations cost $2.6 billion annually - Brain Cancer Epidemiology
Research on brain cancer epidemiology detailed by scientists at Eli Lilly and Company - Business & Finance
Akers Bioscience reports 2006 revenues expected to be $5.2 million in fourth growth year - Business Update
Accenture prototype shows benefits of nationwide health information network - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
